Altre lingue Acarix AB

Azioni

ACARIX

SE0009268717

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:29:42 04/06/2024			Variaz. 5gg	Var. 1 gen.
0,3 ^SEK	-4,61%		-9,77%	+58,06%

27/05	Acarix AB (Publ) nomina Jeff Thomas come nuovo responsabile delle vendite negli Stati Uniti, con effetto dal 1? giugno 2024	CI
14/05	Transcript : Acarix AB, Q1 2024 Earnings Call, May 14, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Acarix welcomes Jeff Thomas as new Head of US Sales	27/05
Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024	27/05
Acarix CPT III Code Removed from United Healthcare Medicare Advantage Noncovered List	20/05
Acarix Q1 2024 - Soft sales but strong outlook	15/05
Announcement from the annual general meeting in Acarix AB	14/05
Acarix AB Approves Board Elections	14/05
Acarix AB (publ) publishes Interim Report, January – March 2024	14/05
Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida	13/05
Acarix Secures Multi-Unit Order from Major Cardiology Practice with Several Offices in Florida	13/05
Invitation to presentation of Acarix´s first quarter report	10/05
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region	06/05
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)	03/05
Acarix receives order from the first freestanding Emergency Room in the US	29/04
Acarix Receives Order from the First Freestanding Emergency Room in the Us	29/04
Acarix AB’s Annual Report 2023	23/04
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB	11/04
Acarix announces the initiation of the first US-based clinical workflow evaluation study	11/04
Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study	11/04
Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review	11/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Acarix AB

Azioni

ACARIX

SE0009268717

Altre lingue

Filtri